Original Research
Published on 15 Mar 2021
Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation
in Cell Growth and Division
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.647713
- 6,073 views
- 15 citations






